Rapidly progressive glomerulonephritides are relatively rare but serious disorders of diverse etiology, which share some clinical features: rapid evolution, progressive to renal failure, often accompanied by oliguria or anuria. They are characterized histopathologically by an intense extracapillary proliferation, with the development of crescents (semilunar lesions) in over 50% of examined glomeruli. The following pathological entities are referred to as rapidly progressive glomerulonephritides: ANCA-positive pauci-immune vasculitides (microscopic polyangiitis, granulomatosis associated with microscopic polyangiitis, allergic granulomatosis associated with microscopic polyangiitis), extracapillary proliferative glomerulonephritides by immune complexes and glomerulonephritides by anti-glomerular basement membrane antibodies. Due to major histopathological and functional complications, their evolution to death or renal replacement therapy occurs within 6-24 months after the diagnosis, if they are not treated, but the evolution is favorably influenced by aggressive immunosuppression, whether or not associated with plasmapheresis.
Introduction
Rapidly progressive glomerulonephritides are relatively rare diseases of diverse etiology, which share some clinical features: rapid evolution, progressive to renal failure, often accompanied by oliguria or anuria. (16) be presented as rapidly progressive glomerulonephritis, haemorrhagic alveolitis or as a combination of the two . (14, 15) Onset is generally acute, with severe acute 
Renal biopsy puncture is mandatory for confirmation of diagnosis.
General Reviews
Proliferative extracapillary glomeru-
lonephritides by immune complexes
They are considered to be the most common pathogenic form of crescentic glomerulonephritis , found more commonly in (22, 23, 24) elderly patients, with equal distribution between genders . Extracapillary forms or in forms refractory to this treatment (7) . Maintaining remission involves combating autoimmunity with cytostatic agents (azathioprine, mycophenolate mofetil or methotrexate) associated with low doses of prednisone.
In the case of ANCA-positive vasculitides, it was observed that without treatment the mortality at 1 year is 80%, but with adequate immunosuppressive therapy, survival at 5 years increases to 75% . Old age, dialysis-dependent upon presentation . The (13) response to treatment is seen in most patients during the first 5 months of treatment . transplantation . In the absence of therapy, (19) the death and / or irreversible degradation of renal function occur in more than 90% of cases. The main causes of early death are pulmonary haemorrhage -by associating acute renal failure with post-hemorrhagic anemia -followed by the occurrence of infections . Prognosis depends on the degree (20) of renal impairment at the time of diagnosis, which is closely related to the level of circulating anti-GBM antibodies. Thus, the survival of the patient and the kidney at 1 year is quantified as follows: 100% -95%, when serum creatinine at presentation is less than 5.7 mg / dL, 83% -82% when serum creatinine is greater than 5.7 mg / dL and 65, and 8% when dialysis was required from the time of diagnosis . Pulmonary haemorrhage may be (21) the leading cause of death in patients with glomerulonephritis by anti-GBM antibodies, but in those who survive pulmonary sequelae are usually minor . Characteristic of (17) glomerulonephritis with anti-GBM antibodies is that relapses are rare; they occur on average 4-7 years after diagnosis and have a frequency of 2-14%, and may affect the kidneys and the lung . (19) In the case of glomerulonephritides associated 
